J. A. Stakkestad

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

Charles H. Chesnut, Arne Skag, Claus Christiansen et al. · Journal of Bone and Mineral Research · 2004 · 1.2K citations · Full text

Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans

Ola Gudmundsen, Henrietta Blankson, J. A. Stakkestad et al. · Journal of Nutrition · 2000 · 597 citations · Full text

Obesity, Metabolic Syndrome, Omega-3 Fatty Acid +7

Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study

Paul D. Miller, Michael R. McClung, Liviu Macovei et al. · Journal of Bone and Mineral Research · 2005 · 333 citations

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study

Pierre D. Delmas, Silvano Adami, Cezary Strugała et al. · Arthritis & Rheumatism · 2006 · 258 citations · Full text

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

Robert R. Recker, J. A. Stakkestad, C. H. Chesnut et al. · Bone · 2004 · 170 citations

Bone Disease, Bone Health, Osteopathy +9